New York State charges Johnson & Johnson over opioid marketing

New York State has filed civil charges against Johnson & Johnson and its affiliate Janssen Pharmaceuticals for insurance fraud. The charges allege that the companies understated the risks and addiction potential of opioid prescriptions to doctors and to elderly patients. The hearing will begin on 25 January 2021.